Cassava Sciences Inc (SAVA)
2.36
+0.07
(+3.06%)
USD |
NASDAQ |
Dec 20, 16:00
2.34
-0.02
(-0.85%)
After-Hours: 20:00
Cassava Sciences Total Liabilities (Quarterly): 57.11M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 76.47B |
| BridgeBio Pharma Inc | 1.883B |
| Seelos Therapeutics Inc | 30.51M |
| Alnylam Pharmaceuticals Inc | 4.173B |
| EyePoint Pharmaceuticals Inc | 82.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 223.75M |
| Shareholders Equity (Quarterly) | 166.64M |